179 related articles for article (PubMed ID: 27780309)
1. Incidental inflammatory adenoma with β-catenin activation in the setting of paediatric NASH.
Oliveira S; Samba AK; Towbin AJ; Gupta A; Geller JI; Nathan JD; Kohli R
Pediatr Obes; 2018 Jan; 13(1):70-73. PubMed ID: 27780309
[TBL] [Abstract][Full Text] [Related]
2. A Limited Immunohistochemical Panel Can Subtype Hepatocellular Adenomas for Routine Practice.
Larson BK; Guindi M
Am J Clin Pathol; 2017 Jun; 147(6):557-570. PubMed ID: 28472207
[TBL] [Abstract][Full Text] [Related]
3. Steatohepatitis-Like Changes in Hepatocellular Adenoma.
Liu Y; Zen Y; Yeh MM
Am J Clin Pathol; 2020 Sep; 154(4):525-532. PubMed ID: 32561910
[TBL] [Abstract][Full Text] [Related]
4. Pigmented hepatocellular adenoma with β-catenin activation: case report and literature review.
Coelho R; Gonçalves R; Carneiro F; Fernandes M; Lopes J; Guimarães S; Macedo G
Ann Hepatol; 2016; 15(4):598-603. PubMed ID: 27236161
[TBL] [Abstract][Full Text] [Related]
5. A case of β-catenin-positive hepatocellular adenoma with MR imaging sign of diffuse intratumoral fat deposition.
Ishii M; Kazaoka J; Fukushima J; Gunji M; Aoyama T; Fukusato T; Sano K; Kondo F; Takeshita T; Furui S; Akahane M
Abdom Imaging; 2015 Aug; 40(6):1487-91. PubMed ID: 25875860
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with nuclear β-catenin and glutamine synthetase positivity: case report and review of the literature.
Hechtman JF; Raoufi M; Fiel MI; Taouli B; Facciuto M; Schiano TD; Blouin AG; Thung SN
Am J Surg Pathol; 2011 Jun; 35(6):927-32. PubMed ID: 21572265
[TBL] [Abstract][Full Text] [Related]
7. Malignant transformation of hepatic adenomas.
Micchelli ST; Vivekanandan P; Boitnott JK; Pawlik TM; Choti MA; Torbenson M
Mod Pathol; 2008 Apr; 21(4):491-7. PubMed ID: 18246041
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
Shafizadeh N; Genrich G; Ferrell L; Kakar S
Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular adenoma in Taiwan: Distinct ensemble of male predominance, overweight/obesity, and inflammatory subtype.
Huang WC; Liau JY; Jeng YM; Liu KL; Lin CN; Song HL; Tsai JH
J Gastroenterol Hepatol; 2020 Apr; 35(4):680-688. PubMed ID: 31698521
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular nodules expressing markers of hepatocellular adenomas in Budd-Chiari syndrome and other rare hepatic vascular disorders.
Sempoux C; Paradis V; Komuta M; Wee A; Calderaro J; Balabaud C; Quaglia A; Bioulac-Sage P
J Hepatol; 2015 Nov; 63(5):1173-80. PubMed ID: 26119687
[TBL] [Abstract][Full Text] [Related]
11. Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon.
Putra J; Ferrell LD; Gouw ASH; Paradis V; Rishi A; Sempoux C; Balabaud C; Thung SN; Bioulac-Sage P
Mod Pathol; 2020 Apr; 33(4):665-675. PubMed ID: 31570768
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular Adenomas: Morphology and Genomics.
Bioulac-Sage P; Sempoux C; Balabaud C
Gastroenterol Clin North Am; 2017 Jun; 46(2):253-272. PubMed ID: 28506364
[TBL] [Abstract][Full Text] [Related]
13. Nuclear beta-catenin staining and absence of steatosis are indicators of hepatocellular adenomas with an increased risk of malignancy.
Van der Borght S; Libbrecht L; Katoonizadeh A; Aerts R; Nevens F; Verslype C; Roskams TA
Histopathology; 2007 Dec; 51(6):855-6. PubMed ID: 17903198
[No Abstract] [Full Text] [Related]
14. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification.
Laumonier H; Bioulac-Sage P; Laurent C; Zucman-Rossi J; Balabaud C; Trillaud H
Hepatology; 2008 Sep; 48(3):808-18. PubMed ID: 18688875
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.
Bioulac-Sage P; Rebouissou S; Thomas C; Blanc JF; Saric J; Sa Cunha A; Rullier A; Cubel G; Couchy G; Imbeaud S; Balabaud C; Zucman-Rossi J
Hepatology; 2007 Sep; 46(3):740-8. PubMed ID: 17663417
[TBL] [Abstract][Full Text] [Related]
16. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
[TBL] [Abstract][Full Text] [Related]
17. Hepatic Adenomas: Classification, Controversies, and Consensus.
Torbenson M
Surg Pathol Clin; 2018 Jun; 11(2):351-366. PubMed ID: 29751879
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular adenoma in the paediatric population: Molecular classification and clinical associations.
Hahn E; Putra J
World J Gastroenterol; 2020 May; 26(19):2294-2304. PubMed ID: 32476794
[TBL] [Abstract][Full Text] [Related]
19. Retrospective study of hepatocellular adenomas based on the phenotypic classification system: A report from China.
Pan J; Chen L; Fan J; Zhou J; Qin L; Tan Y; Ji Y; Huang X
Histol Histopathol; 2014 Feb; 29(2):243-9. PubMed ID: 23939475
[TBL] [Abstract][Full Text] [Related]
20. β-Catenin activated hepatocellular adenoma: a report of three cases in Korea.
Kim GJ; Seok JY; Rhee H; Choi JY; Choi JS; Kim KS; Thung S; Park YN
Gut Liver; 2014 Jul; 8(4):452-8. PubMed ID: 25071913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
